Institution:
University of North Carolina School of Medicine
About:
We are a dynamic multidisciplinary research group studying diabetic vasculopathies. We are part of the Center for Nanotechnology in Drug Delivery at the University of North Carolina – Chapel Hill. Our long term research aims to change the way we treat arterial disease in diabetes by:
- Understanding why arterial disease is more aggressive in diabetic patients, with an emphasis in understanding the redox dysfunction in the vasculature.
- Understanding howother causes of redox dysfunction such as air pollution affect vascular surgery outcomes.
- Developing targeted systems using nanotechnology to locally deliver redox-based therapeutics to the diseased arteries.
